Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD8-HDM Depleted Donor Lymphocyte Infusion for GvHD Prevention in CML
NCT00004878Phase 2Withdrawn
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Modality
- Cell Therapies
01
Overview
A Phase 2 trial of CD8-depleted donor lymphocytes in graft-versus-host disease (GVHD), chronic myeloid leukemia (CML), sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: withdrawn.
02
Drugs
CD8-depleted donor lymphocytes
03
Conditions
graft-versus-host disease (GVHD)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00004878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004878.